Hydra Biosciences, biopharmaceutical company, Cambridge, Massachusetts, novel drugs important human diseases, major therapeutic areas, pain, cardiovascular disease, transient receptor potential (TRP) ion channels, molecular regeneration.
Description
pulled from site's meta descriptionHydra Biosciences is committed to developing novel drugs to treat important human diseases in major therapeutic areas using its expertise in ion channels and regeneration
Domain Resolution
This domain resolves to the following IP addresses:This is an automatically generated AboutUs page for Hydrabioscience.com. Click the "Edit" button at the top of the page to make changes. Please read our Getting Started page if you need any help.
Categories:
- AboutUs AutoGen
- Hydra Biosciences
- Hydra
- biosciences
- biotech
- biotechnology
- biopharmaceutical
- Cambridge
- MA
- Massachusetts
- ion channel
- transient receptor potential
- TRP
- cardiac regeneration
- cardiac
- regeneration
- pain
- inflammation
- therapeutic
- research
- drug discovery
- drug development
- cardiovascular
- heart
- disease
- acute myocardial infarction
- AMI
- congestive heart failure
- CHF
- medicines
- novel
- therapy
- protein
- factors
- recombinant
- pharmacokinetics
- molecular
- smooth muscle
- GSK-3 inhibitors
- signal integrators
- vanilloid receptor
- gated
- signal transduction
- Mark Keating
- David Clapham